Overview
Current NAV
42.5340
As on 30-Dec-2025
Fund Size
2,812.118 Cr
Managed by Neelesh Surana
Expense Ratio
0.48%
Latest reported
Exit Load Rules
1
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 02-Jul-2018. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.61 | — | — | — |
| 1W | -1.37 | — | — | — |
| 1M | -1.72 | — | — | — |
| 3M | 1.05 | — | 1.47 | — |
| 6M | 1.12 | — | 0.20 | — |
| 1Y | -1.10 | — | -2.14 | — |
| 3Y | 23.22 | 23.22 | 22.11 | — |
| 5Y | 16.80 | 16.80 | 14.61 | — |
| 10Y | — | — | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
13.06
Divi's Laboratories Ltd.
EQ
Healthcare
8.56
Glenmark Pharmaceuticals Ltd.
EQ
Healthcare
6.51
Apollo Hospitals Enterprise Ltd.
EQ
Healthcare
5.95
Cipla Ltd.
EQ
Healthcare
5.54
Lupin Ltd.
EQ
Healthcare
5.18
Aurobindo Pharma Ltd.
EQ
Healthcare
4.33
Dr. Reddy's Laboratories Ltd.
EQ
Healthcare
4.24
Fortis Healthcare Ltd.
EQ
Healthcare
4.21
Ipca Laboratories Ltd.
EQ
Healthcare
3.74
Krishna Institute of Medical Sciences Ltd
EQ
Healthcare
3.59
Aster DM Healthcare Ltd.
EQ
Healthcare
3.43
Analysis Highlights
PROS
Lower expense ratio: 0.48%
PROS
Consistently higher annualised returns than category average for the past 1Y, 3Y and 5Y
CONS
Low rating: 2
Exit Load
- Exit load of 1% if redeemed within 1 year.2018-06-11